| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.FREERADBIOMED.2005.03.020 |
| P698 | PubMed publication ID | 15993337 |
| P50 | author | Kathy K. Griendling | Q52725890 |
| P2093 | author name string | Bernard Lassègue | |
| John F Keaney | |||
| Kai Chen | |||
| Ulrich Walter | |||
| Andreas Daiber | |||
| Thomas Münzel | |||
| Karsten Sydow | |||
| Eberhard Schulz | |||
| Andrei L Kleschyov | |||
| Alexander Mülsch | |||
| Maria C Wendt | |||
| P2860 | cites work | Cell transformation by the superoxide-generating oxidase Mox1 | Q22010372 |
| P433 | issue | 3 | |
| P304 | page(s) | 381-391 | |
| P577 | publication date | 2005-04-07 | |
| P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
| P1476 | title | Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. | |
| P478 | volume | 39 |
| Q37694033 | A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress |
| Q46130828 | Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms? |
| Q35602720 | Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis |
| Q26991619 | Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system |
| Q36022741 | Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats. |
| Q46284193 | CD40L controls obesity-associated vascular inflammation, oxidative stress and endothelial dysfunction in mice - translational aspects for man. |
| Q38667506 | Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. |
| Q34350546 | Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature |
| Q39937826 | Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice |
| Q44246845 | Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus |
| Q28582183 | Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine |
| Q86207080 | Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats |
| Q92420811 | Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? |
| Q36507302 | Endothelial dysfunction in diabetic erectile dysfunction |
| Q58477477 | HUVECs from newborns with a strong family history of diabetes show diminished ROS synthesis in the presence of high glucose concentrations |
| Q36759153 | Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability |
| Q39177176 | Increased monocyte-derived reactive oxygen species in type 2 diabetes: role of endoplasmic reticulum stress |
| Q84958668 | Increased nitric oxide activity compensates for increased oxidative stress to maintain endothelial function in rat aorta in early type 1 diabetes |
| Q43244384 | Lignin-derived lignophenols attenuate oxidative and inflammatory damage to the kidney in streptozotocin-induced diabetic rats |
| Q44438022 | Localization and Interaction between Kinin B1 Receptor and NADPH Oxidase in the Vascular System of Diabetic Rats |
| Q37608376 | Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction |
| Q33929661 | Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. |
| Q33940901 | Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes |
| Q28660732 | Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress |
| Q33593365 | NAD(P)H oxidases in coronary artery disease. |
| Q42072724 | NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose. |
| Q27001094 | NADPH oxidases in heart failure: poachers or gamekeepers? |
| Q33739287 | NADPH oxidases: functions and pathologies in the vasculature |
| Q41703303 | NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis. |
| Q37805535 | Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. |
| Q36052377 | Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy |
| Q37760616 | Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. |
| Q37392163 | Nox proteins in signal transduction |
| Q34631886 | Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy |
| Q42016966 | Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function. |
| Q36729012 | Nox2 deficiency prevents hypertension-induced vascular dysfunction and hypertrophy in cerebral arterioles |
| Q37270928 | Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes |
| Q39349571 | Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. |
| Q37699822 | Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension |
| Q46965143 | Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice |
| Q42729021 | Protection of the vascular endothelium in experimental situations |
| Q35222727 | Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling |
| Q42946155 | Protein tyrosine phosphatase PTPεM negatively regulates PDGF β-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells |
| Q37360478 | Rac1 is required for cardiomyocyte apoptosis during hyperglycemia |
| Q59279106 | Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes |
| Q26801347 | Redox implications in adipose tissue (dys)function--A new look at old acquaintances |
| Q36741267 | Regulation of ROS signal transduction by NADPH oxidase 4 localization |
| Q54295290 | Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. |
| Q38000380 | Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited |
| Q35630866 | Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: a give-and-take relationship |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q85343361 | Spironolactone improves endothelial dysfunction in streptozotocin-induced diabetic rats |
| Q46508181 | Studying neuroprotective effect of Atorvastatin as a small molecule drug on high glucose-induced neurotoxicity in undifferentiated PC12 cells: role of NADPH oxidase. |
| Q28566200 | Subcellular localization of Nox4 and regulation in diabetes |
| Q37947602 | Targeting endothelial dysfunction in vascular complications associated with diabetes |
| Q42747102 | Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. |
| Q36060782 | The NOX toolbox: validating the role of NADPH oxidases in physiology and disease |
| Q80300386 | The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo |
| Q36961504 | The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes |
| Q38200957 | The pathobiology of diabetic vascular complications--cardiovascular and kidney disease |
| Q38858553 | Therapeutic potential of NADPH oxidase 1/4 inhibitors |
| Q37380419 | Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling |
| Q58592584 | Vascular biology of superoxide-generating NADPH oxidase 5 (Nox5)- implications in hypertension and cardiovascular disease |
| Q35227188 | Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy |
| Q34479731 | Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease |
Search more.